{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:29:50Z","timestamp":1793384990073,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["67033"],"award-info":[{"award-number":["67033"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-025-00408-4","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:43:53Z","timestamp":1766083433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The promising effects of a multi-species synbiotic preparation on metabolic profile in elderly patients with type 2 diabetes and high cardiovascular risk: a randomized, triple-blind, placebo-controlled trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-1003","authenticated-orcid":false,"given":"Neda","family":"Dolatkhah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Nourizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Aghamohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Yahyavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Eslamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hashemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"408_CR1","first-page":"787","volume":"88","author":"RA DeFronzo","year":"2004","unstructured":"DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin. 2004;88:787\u2013835.","journal-title":"Med Clin"},{"key":"408_CR2","volume":"2020","author":"F Chen","year":"2020","unstructured":"Chen F, Xu S, Wang Y, Chen F, Cao L, Liu T, et al. Risk factors for sarcopenia in the elderly with type 2 diabetes mellitus and the effect of metformin. J Diabetes Res. 2020;2020:3950404.","journal-title":"J Diabetes Res"},{"key":"408_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0897190003261310","volume":"17","author":"D Schering","year":"2004","unstructured":"Schering D, Kasten S. The link between diabetes and cardiovascular disease. J Pharm Pract. 2004;17:61\u20135.","journal-title":"J Pharm Pract"},{"key":"408_CR4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","volume":"5","author":"I Mart\u00edn-Tim\u00f3n","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, Sevillano-Collantes C, Segura-Galindo A, del Ca\u00f1izo-G\u00f3mez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5:444.","journal-title":"World J Diabetes"},{"key":"408_CR5","first-page":"653789","volume":"2013","author":"ASDM Matheus","year":"2013","unstructured":"Matheus ASDM, Tannus LRM, Cobas RA, Palma CCS, Negrato CA, MdB Gomes. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789.","journal-title":"Int J Hypertens"},{"key":"408_CR6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6:1246.","journal-title":"World J Diabetes"},{"key":"408_CR7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/nu14010166","volume":"14","author":"CO Iatcu","year":"2021","unstructured":"Iatcu CO, Steen A, Covasa M. Gut microbiota and complications of type-2 diabetes. Nutrients. 2021;14:166.","journal-title":"Nutrients"},{"key":"408_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101438","volume":"57","author":"D Gueddouri","year":"2022","unstructured":"Gueddouri D, Ca\u00fczac M, Fauveau V, Benhamed F, Charifi W, Beaudoin L, et al. Insulin resistance per se drives early and reversible dysbiosis-mediated gut barrier impairment and bactericidal dysfunction. Mol Metab. 2022;57:101438.","journal-title":"Mol Metab"},{"key":"408_CR9","doi-asserted-by":"crossref","unstructured":"Afolayan A, Adebusoye L, Cadmus E, Ayeni F Insights into the gut microbiota of Nigerian elderly with type 2 diabetes and non-diabetic elderly persons. Heliyon. 2020;6:e03971.","DOI":"10.1016\/j.heliyon.2020.e03971"},{"key":"408_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nutres.2015.03.002","volume":"35","author":"C He","year":"2015","unstructured":"He C, Shan Y, Song W. Targeting gut microbiota as a possible therapy for diabetes. Nutr Res. 2015;35:361\u20137.","journal-title":"Nutr Res"},{"key":"408_CR11","first-page":"581","volume":"27","author":"M Hajifaraji","year":"2018","unstructured":"Hajifaraji M, Jahanjou F, Abbasalizadeh F, Aghamohammadzadeh N, Abbasi MM, Dolatkhah N. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial. Asia Pac J Clin Nutr. 2018;27:581\u201391.","journal-title":"Asia Pac J Clin Nutr"},{"key":"408_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41043-015-0034-9","volume":"33","author":"N Dolatkhah","year":"2015","unstructured":"Dolatkhah N, Hajifaraji M, Abbasalizadeh F, Aghamohammadzadeh N, Mehrabi Y, Mesgari Abbasi M. Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial. J Health Popul Nutr. 2015;33:1\u20138.","journal-title":"J Health Popul Nutr"},{"key":"408_CR13","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1093\/cid\/civ177","volume":"60","author":"R Patel","year":"2015","unstructured":"Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60:S108\u2013S21.","journal-title":"Clin Infect Dis"},{"key":"408_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.13005\/bpj\/357","volume":"5","author":"T Manigandan","year":"2012","unstructured":"Manigandan T, Mangaiyarkarasi S, Hemalatha R, Hemalatha V, Murali N. Probiotics, prebiotics and synbiotics-a review. Biomed Pharmacol J. 2012;5:295.","journal-title":"Biomed Pharmacol J"},{"key":"408_CR15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","volume":"9","author":"P Markowiak","year":"2017","unstructured":"Markowiak P, \u015ali\u017cewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9:1021.","journal-title":"Nutrients"},{"key":"408_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/426027","volume":"40","author":"S Bartosch","year":"2005","unstructured":"Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis. 2005;40:28\u201337.","journal-title":"Clin Infect Dis"},{"key":"408_CR17","volume":"12","author":"EC Ale","year":"2021","unstructured":"Ale EC, Binetti AG. Role of probiotics, prebiotics, and synbiotics in the elderly: insights into their applications. Front Microbiol. 2021;12:631254.","journal-title":"Front Microbiol"},{"key":"408_CR18","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/nu13082514","volume":"13","author":"A Bia\u0142ecka-D\u0119bek","year":"2021","unstructured":"Bia\u0142ecka-D\u0119bek A, Granda D, Szmidt MK, Zieli\u0144ska D. Gut microbiota, probiotic interventions, and cognitive function in the elderly: a review of current knowledge. Nutrients. 2021;13:2514.","journal-title":"Nutrients"},{"key":"408_CR19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12603-023-1921-1","volume":"27","author":"R Shen","year":"2023","unstructured":"Shen R, Chen S, Lei W, Shen J, Lv L, Wei T. Nonfood probiotic, prebiotic, and synbiotic use reduces all-cause and cardiovascular mortality risk in older adults: a population-based cohort study. J Nutr Health Aging. 2023;27:391\u20137.","journal-title":"J Nutr Health Aging"},{"key":"408_CR20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.31989\/ffhd.v9i7.617","volume":"9","author":"N Kassaian","year":"2019","unstructured":"Kassaian N, Feizi A, Aminorroaya A, Ebrahimi MT, Norouzi A, Amini M. Effects of probiotics and synbiotic on lipid profiles in adults at risk of type 2 diabetes: a double-blind randomized controlled clinical trial. Funct Foods Health Dis. 2019;9:494\u2013507.","journal-title":"Funct Foods Health Dis"},{"key":"408_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106288","volume":"182","author":"K Naseri","year":"2022","unstructured":"Naseri K, Saadati S, Ghaemi F, Ashtary-Larky D, Asbaghi O, Sadeghi A, et al. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol Res. 2022;182:106288.","journal-title":"Pharmacol Res"},{"key":"408_CR22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00394-020-02271-8","volume":"60","author":"AF Cicero","year":"2021","unstructured":"Cicero AF, Fogacci F, Bove M, Giovannini M, Borghi C. Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. Eur J Nutr. 2021;60:655\u201363.","journal-title":"Eur J Nutr"},{"key":"408_CR23","first-page":"233","volume":"20","author":"SH Yu","year":"2020","unstructured":"Yu SH. Management of cardiovascular risk factors in elderly diabetes mellitus patients. J Korean Diabetes. 2020;20:233\u20138.","journal-title":"J Korean Diabetes"},{"key":"408_CR24","doi-asserted-by":"crossref","unstructured":"Ohnishi H, Saitoh S. Obesity and diabetes mellitus as risk factors for cardiovascular disease in the elderly. In: Health Issues and Care System for the Elderly. Singapore: Springer; 2019. p. 97\u2013106.","DOI":"10.1007\/978-981-13-1762-0_7"},{"key":"408_CR25","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"Association AD. 2.","year":"2021","unstructured":"Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142021. Diabetes Care. 2021;44:S15\u2013S33.","journal-title":"Diabetes Care"},{"key":"408_CR26","doi-asserted-by":"crossref","first-page":"e0225168","DOI":"10.1371\/journal.pone.0225168","volume":"14","author":"RS Madempudi","year":"2019","unstructured":"Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: a double blind, randomized, placebo controlled study. PLoS ONE. 2019;14:e0225168.","journal-title":"PLoS ONE"},{"key":"408_CR27","first-page":"353","volume":"19","author":"T Dunning","year":"2015","unstructured":"Dunning T. Overview of cardiovascular risk in older people with diabetes: Basic pathophysiology, risk factors and management. J Diabetes Nurs. 2015;19:353\u20139.","journal-title":"J Diabetes Nurs"},{"key":"408_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28982-x","volume":"8","author":"B Moreno-Franco","year":"2018","unstructured":"Moreno-Franco B, P\u00e9rez-Tasigchana RF, Lopez-Garcia E, Laclaustra M, Gutierrez-Fisac JL, Rodr\u00edguez-Artalejo F, et al. Socioeconomic determinants of sarcopenic obesity and frail obesity in community-dwelling older adults: The Seniors-ENRICA Study. Sci Rep. 2018;8:10760.","journal-title":"Sci Rep"},{"key":"408_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1532-5415.1986.tb06336.x","volume":"34","author":"W Kannel","year":"1986","unstructured":"Kannel W. Nutritional contributors to cardiovascular disease in the elderly. J Am Geriatr Soc. 1986;34:27\u201336.","journal-title":"J Am Geriatr Soc"},{"key":"408_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3920\/BM2016.0115","volume":"8","author":"R Vemuri","year":"2017","unstructured":"Vemuri R, Gundamaraju R, Shinde T, Eri R. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation? Benef Microbes. 2017;8:179\u201392.","journal-title":"Benef Microbes"},{"key":"408_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijfoodmicro.2014.04.016","volume":"184","author":"E Suffredini","year":"2014","unstructured":"Suffredini E, Mioni R, Mazzette R, Bordin P, Serratore P, Fois F, et al. Detection and quantification of Vibrio parahaemolyticus in shellfish from Italian production areas. Int J Food Microbiol. 2014;184:14\u201320.","journal-title":"Int J Food Microbiol"},{"key":"408_CR32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/biology10040322","volume":"10","author":"ID Kwoji","year":"2021","unstructured":"Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Multi-strain probiotics: synergy among isolates enhances biological activities. Biology. 2021;10:322.","journal-title":"Biology"},{"key":"408_CR33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/09637486.2015.1136905","volume":"67","author":"C Altieri","year":"2016","unstructured":"Altieri C, Iorio MC, Bevilacqua A, Sinigaglia M. Influence of prebiotics on Lactobacillus reuteri death kinetics under sub-optimal temperatures and pH. Int J Food Sci Nutr. 2016;67:92\u20138.","journal-title":"Int J Food Sci Nutr"},{"key":"408_CR34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1472-765X.2008.02539.x","volume":"48","author":"X Pan","year":"2009","unstructured":"Pan X, Wu T, Zhang L, Cai L, Song Z. Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli to simulated stress environment. Lett Appl Microbiol. 2009;48:362\u20137.","journal-title":"Lett Appl Microbiol"},{"key":"408_CR35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ijbiomac.2020.02.318","volume":"152","author":"L Huang","year":"2020","unstructured":"Huang L, Shen M, Wu T, Yu Y, Yu Q, Chen Y, et al. Mesona chinensis Benth polysaccharides protect against oxidative stress and immunosuppression in cyclophosphamide-treated mice via MAPKs signal transduction pathways. Int J Biol Macromol. 2020;152:766\u201374.","journal-title":"Int J Biol Macromol"},{"key":"408_CR36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/nu12041037","volume":"12","author":"MP Guarino","year":"2020","unstructured":"Guarino MP, Altomare A, Emerenziani S, Di Rosa C, Ribolsi M, Balestrieri P, et al. Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults. Nutrients. 2020;12:1037.","journal-title":"Nutrients"},{"key":"408_CR37","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00394-013-0648-x","volume":"53","author":"M Scheid","year":"2014","unstructured":"Scheid M, Genaro P, Moreno Y, Pastore G. Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly. Eur J Nutr. 2014;53:1457\u201364.","journal-title":"Eur J Nutr"},{"key":"408_CR38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3920\/BM2019.0052","volume":"10","author":"MR Sudha","year":"2019","unstructured":"Sudha MR, Ahire J, Jayanthi N, Tripathi A, Nanal S. Effect of multi-strain probiotic (UB0316) in weight management in overweight\/obese adults: A 12-week double blind, randomised, placebo-controlled study. Benef Microbes. 2019;10:855\u201366.","journal-title":"Benef Microbes"},{"key":"408_CR39","volume":"9","author":"AC Chen","year":"2022","unstructured":"Chen AC, Fang TJ, Ho HH, Chen JF, Kuo YW, Huang YY, et al. A multi-strain probiotic blend reshaped obesity-related gut dysbiosis and improved lipid metabolism in obese children. Front Nutr. 2022;9:922993.","journal-title":"Front Nutr"},{"key":"408_CR40","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.3390\/nu12123758","volume":"12","author":"J Smarkusz-Zarzecka","year":"2020","unstructured":"Smarkusz-Zarzecka J, Ostrowska L, Leszczy\u0144ska J, Orywal K, Cwalina U, Pogodzi\u0144ski D. Analysis of the impact of a multi-strain probiotic on body composition and cardiorespiratory fitness in long-distance runners. Nutrients. 2020;12:3758.","journal-title":"Nutrients"},{"key":"408_CR41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nutres.2015.05.008","volume":"35","author":"S Park","year":"2015","unstructured":"Park S, Bae J-H. Probiotics for weight loss: a systematic review and meta-analysis. Nutr Res. 2015;35:566\u201375.","journal-title":"Nutr Res"},{"key":"408_CR42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2011.01.076","volume":"155","author":"TE Dorner","year":"2012","unstructured":"Dorner TE, Rieder A. Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol. 2012;155:56\u201365.","journal-title":"Int J Cardiol"},{"key":"408_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13679-015-0161-z","volume":"4","author":"LE Gill","year":"2015","unstructured":"Gill LE, Bartels SJ, Batsis JA. Weight management in older adults. Curr Obes Rep. 2015;4:379\u201388.","journal-title":"Curr Obes Rep"},{"key":"408_CR44","doi-asserted-by":"crossref","unstructured":"Zhao J, Huang Y, Yu X. A narrative review of gut-muscle axis and sarcopenia: the potential role of gut microbiota. Int J Gen Med. 2021;14:1263\u201373.","DOI":"10.2147\/IJGM.S301141"},{"key":"408_CR45","doi-asserted-by":"crossref","first-page":"838S","DOI":"10.1093\/jn\/137.3.838S","volume":"137","author":"KE Scholz-Ahrens","year":"2007","unstructured":"Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Asil Y, et al. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr. 2007;137:838S\u201346S.","journal-title":"J Nutr"},{"key":"408_CR46","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1017\/S0007114500001082","volume":"83","author":"G Riccardi","year":"2000","unstructured":"Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndrome\u2014the optimal diet. Br J Nutr. 2000;83:S143\u2013S8.","journal-title":"Br J Nutr"},{"key":"408_CR47","doi-asserted-by":"crossref","first-page":"e0132121","DOI":"10.1371\/journal.pone.0132121","volume":"10","author":"Y Ruan","year":"2015","unstructured":"Ruan Y, Sun J, He J, Chen F, Chen R, Chen H. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials. PLoS ONE. 2015;10:e0132121.","journal-title":"PLoS ONE"},{"key":"408_CR48","volume":"9","author":"A Kordowski","year":"2022","unstructured":"Kordowski A, Tetzlaff-Lelleck VV, Speckmann B, Loh G, K\u00fcnstner A, Schulz F, et al. A nutritional supplement based on a synbiotic combination of Bacillus subtilis DSM 32315 and L-alanyl-L-glutamine improves glucose metabolism in healthy prediabetic subjects\u2013A real-life post-marketing study. Front Nutr. 2022;9:1001419.","journal-title":"Front Nutr"},{"key":"408_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0042-105441","volume":"125","author":"M Tajabadi-Ebrahimi","year":"2017","unstructured":"Tajabadi-Ebrahimi M, Sharifi N, Farrokhian A, Raygan F, Karamali F, Razzaghi R, et al. A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease. Exp Clin Endocrinol Diabetes. 2017;125:21\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"408_CR50","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00394-019-02135-w","volume":"59","author":"A Horvath","year":"2020","unstructured":"Horvath A, Leber B, Feldbacher N, Tripolt N, Rainer F, Blesl A, et al. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. Eur J Nutr. 2020;59:2969\u201383.","journal-title":"Eur J Nutr"},{"key":"408_CR51","doi-asserted-by":"publisher","unstructured":"Piper S, Jiwani S, Gyasi-Antwi P, Adams G. The benefits and risks of probiotic, prebiotic and symbiotic interventions in the care of patients with diabetes mellitus. Int J Diabetes Endocrinol. 2021; https:\/\/doi.org\/10.46715\/ijde2021.02.1000110.","DOI":"10.46715\/ijde2021.02.1000110"},{"key":"408_CR52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4236\/aim.2013.32032","volume":"3","author":"S van Hemert","year":"2013","unstructured":"van Hemert S, Verwer J, Sch\u00fctz B. Clinical studies evaluating effects of probiotics on parameters of intestinal barrier function. Adv Microbiol. 2013;3:212\u201321.","journal-title":"Adv Microbiol"},{"key":"408_CR53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S095442241700018X","volume":"31","author":"Y Kim","year":"2018","unstructured":"Kim Y, Keogh J, Clifton P. Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr Res Rev. 2018;31:35\u201351.","journal-title":"Nutr Res Rev"},{"key":"408_CR54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200.","journal-title":"Gut Microbes"},{"key":"408_CR55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00253-018-9570-8","volume":"103","author":"F Bianchi","year":"2019","unstructured":"Bianchi F, Duque ALRF, Saad SMI, Sivieri K. Gut microbiome approaches to treat obesity in humans. Appl Microbiol Biotechnol. 2019;103:1081\u201394.","journal-title":"Appl Microbiol Biotechnol"},{"key":"408_CR56","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11745-014-3901-z","volume":"49","author":"H Shakeri","year":"2014","unstructured":"Shakeri H, Hadaegh H, Abedi F, Tajabadi-Ebrahimi M, Mazroii N, Ghandi Y, et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids. 2014;49:695\u2013701.","journal-title":"Lipids"},{"key":"408_CR57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00125-020-05295-1","volume":"64","author":"PM Bock","year":"2021","unstructured":"Bock PM, Telo GH, Ramalho R, Sbaraini M, Leivas G, Martins AF, et al. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Diabetologia. 2021;64:26\u201341.","journal-title":"Diabetologia"},{"key":"408_CR58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.15171\/apb.2018.065","volume":"8","author":"S Mahboobi","year":"2018","unstructured":"Mahboobi S, Rahimi F, Jafarnejad S. Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: a meta-analysis of randomized controlled trials. Adv Pharm Bull. 2018;8:565.","journal-title":"Adv Pharm Bull"},{"key":"408_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2023.100367","volume":"27","author":"S Salamat","year":"2024","unstructured":"Salamat S, Tabandeh MR, Jahan-Mihan A, Mansoori A. The effect of supplementation with a multi-species synbiotic on serum lipid profile, abundance of beneficial gut bacteria and firmicutes to bacteroidetes ratio in patients with dyslipidemia; a randomized, double-blind, placebo-controlled, clinical trial. PharmaNutrition. 2024;27:100367.","journal-title":"PharmaNutrition"},{"key":"408_CR60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1074248414555004","volume":"20","author":"H Rajkumar","year":"2015","unstructured":"Rajkumar H, Kumar M, Das N, Kumar SN, Challa HR, Nagpal R. Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J Cardiovasc Pharmacol Ther. 2015;20:289\u201398.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"408_CR61","doi-asserted-by":"crossref","first-page":"117487","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh V, Kaur R, Kumari P, Pasricha C, Singh R. ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta. 2023;548:117487.","journal-title":"Clin Chim Acta"},{"key":"408_CR62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2006.09.015","volume":"193","author":"GD Norata","year":"2007","unstructured":"Norata GD, Grigore L, Raselli S, Redaelli L, Hamsten A, Maggi F, et al. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis. 2007;193:321\u20137.","journal-title":"Atherosclerosis"},{"key":"408_CR63","doi-asserted-by":"crossref","first-page":"E168","DOI":"10.1152\/ajpendo.00064.2015","volume":"309","author":"JM Perkins","year":"2015","unstructured":"Perkins JM, Joy NG, Tate DB, Davis SN. Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans. Am J Physiol Endocrinol Metab. 2015;309:E168\u2013E76.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"408_CR64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166170","volume":"1867","author":"MF Troncoso","year":"2021","unstructured":"Troncoso MF, Ortiz-Quintero J, Garrido-Moreno V, Sanhueza-Olivares F, Guerrero-Moncayo A, Chiong M, et al. VCAM-1 as a predictor biomarker in cardiovascular disease. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166170.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"408_CR65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.118.313565","volume":"123","author":"M Malik","year":"2018","unstructured":"Malik M, Suboc TM, Tyagi S, Salzman N, Wang J, Ying R, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res. 2018;123:1091\u2013102.","journal-title":"Circ Res"},{"key":"408_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-018-2371-x","volume":"18","author":"C Tenorio-Jim\u00e9nez","year":"2018","unstructured":"Tenorio-Jim\u00e9nez C, Mart\u00ednez-Ram\u00edrez MJ, Tercero-Lozano M, Arraiza-Irigoyen C, Del Castillo-Codes I, Olza J, et al. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR). BMC Complement Altern Med. 2018;18:1\u20138.","journal-title":"BMC Complement Altern Med"},{"key":"408_CR67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nut.2018.12.011","volume":"62","author":"L Rezazadeh","year":"2019","unstructured":"Rezazadeh L, Gargari BP, Jafarabadi MA, Alipour B. Effects of probiotic yogurt on glycemic indexes and endothelial dysfunction markers in patients with metabolic syndrome. Nutrition. 2019;62:162\u20138.","journal-title":"Nutrition"},{"key":"408_CR68","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/nu10111672","volume":"10","author":"M Szuli\u0144ska","year":"2018","unstructured":"Szuli\u0144ska M, \u0141oniewski I, Skrypnik K, Sobieska M, Korybalska K, Suliburska J, et al. Multispecies probiotic supplementation favorably affects vascular function and reduces arterial stiffness in obese postmenopausal women\u2014A 12-week placebo-controlled and randomized clinical study. Nutrients. 2018;10:1672.","journal-title":"Nutrients"},{"key":"408_CR69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcn\/32.1.19","volume":"32","author":"G Hepner","year":"1979","unstructured":"Hepner G, Fried R, St Jeor S, Fusetti L, Morin R. Hypocholesterolemic effect of yogurt and milk. Am J Clin Nutr. 1979;32:19\u201324.","journal-title":"Am J Clin Nutr"},{"key":"408_CR70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10409230290771519","volume":"37","author":"DI Pereira","year":"2002","unstructured":"Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol. 2002;37:259\u201381.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"408_CR71","volume":"366","author":"J Jiang","year":"2019","unstructured":"Jiang J, Feng N, Zhang C, Liu F, Zhao J, Zhang H, et al. Lactobacillus reuteri A9 and Lactobacillus mucosae A13 isolated from Chinese superlongevity people modulate lipid metabolism in a hypercholesterolemia rat model. FEMS Microbiol Lett. 2019;366:fnz254.","journal-title":"FEMS Microbiol Lett"},{"key":"408_CR72","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1253\/circj.CJ-12-0428","volume":"76","author":"M Koshizaka","year":"2012","unstructured":"Koshizaka M, Green JB, Alexander JH. Glycemic management in diabetes and the associated cardiovascular risk\u2013Are we helping or hurting our patients? Circ J. 2012;76:1572\u201380.","journal-title":"Circ J"},{"key":"408_CR73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00325481.2017.1246346","volume":"129","author":"E McNicholas","year":"2017","unstructured":"McNicholas E, Abdelhafiz AH. Diabetes management in older people: a focus on cardiovascular risk reduction. Postgrad Med. 2017;129:169\u201377.","journal-title":"Postgrad Med"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00408-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:35:19Z","timestamp":1767620119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00408-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1038\/s41387-025-00408-4","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no competing interests regarding the research conducted and reported in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No AI-assisted technologies were employed during the preparation of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"2"}}